Therapeutic Potential of Cannabinoids in Glaucoma
Abstract Glaucoma is a leading cause of irreversible blindness worldwide. To date, intraocular pressure (IOP) is the only modifiable risk…
Abstract Glaucoma is a leading cause of irreversible blindness worldwide. To date, intraocular pressure (IOP) is the only modifiable risk…
Abstract Background: Preclinical and human data suggest that psychosis onset involves hippocampal glutamatergic dysfunction, driving hyperactivity and hyperperfusion in a…
Abstract We report studies pertaining to two isomeric hexahydrocannabinols (HHCs), (9R)-HHC and (9S)-HHC, which are derivatives of the psychoactive cannabinoids…
Abstract Background: Substance use/abuse is a global challenge that has detrimental effects on nations’ health, wealth, and security. Substance users…
Abstract The present study describes the development of novel block copolymer nanocarriers of the phytocannabinoid cannabidiol (CBD), designed to enhance…
Abstract Background: AB-CHMINACA is a cannabimimetic indazole derivative. In 2013, it was reported in different countries as a substance of…
Abstract Currently, there is no cure for human immunodeficiency virus type 1 (HIV-1) infection. However, combined antiretroviral therapy (cART) aids…
Abstract Objective: Cannabis use among veterans in Canada is an understudied public health priority. The current study examined cannabis use…
Abstract Chronic comorbid conditions are common in adults with asthma, and some may influence a patient’s asthma exacerbation risk. We…
Abstract Introduction: Drug use behaviors are closely associated with increased risk for HIV and other STIs among men who have…